Episode Details

Back to Episodes

Eye Cancer Isn't the Hardest Part...This Is

Published 3 months, 4 weeks ago
Description

Ocular melanoma is a rare and aggressive eye cancer — and in this episode, Mychellya shares what it’s really like to live through it. From undergoing plaque radiation therapy (including a surgically implanted 24-karat gold plaque) to navigating vision changes, isolation, and the fear of the unknown, this is an honest eye cancer journey you won’t hear on Google.


After being one of the rare patients approved for a second round of plaque radiation for ocular melanoma, Mychellya returns one year later to share what has changed — physically, emotionally, and spiritually.


Inside this episode:


✅ What plaque radiation therapy for eye cancer actually involves

✅ Being isolated in the hospital while radioactive

✅ The mental battle of uncertainty vs. staying present

✅ “The unknown is always the fear factor”

✅ Her first hopeful scan: “It’s starting to show signs of response”

✅ Double vision, driving again after seven months, and recovery updates

✅ The human side of healthcare and trusting your care team

✅ How crushing seasons can create unexpected purpose


This isn’t just an eye cancer update. It’s a conversation about resilience, faith, mental strength, and learning to live fully while waiting for answers.


If you or someone you love is navigating ocular melanoma, cancer treatment, chronic illness, or a season of uncertainty, this episode offers perspective, hope, and real-life experience from someone walking it in real time.


📱 Follow The DEVICE Girls for more real conversations that humanize healthcare and amplify stories that matter.


Connect with us:

Instagram:

@sarahekruse

@haleygibssonfit


Follow Mychellya:

@mychellya


Views Expressed Are Our Own


#OcularMelanoma #EyeCancer #EyeCancerJourney #PlaqueRadiation #CancerStory #CancerRecovery #FaithOverFear #MedicalPodcast #HealthcareStories #WomenInMedicine #TheDeviceGirls

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us